Vecuronium Bromide Flashcards

Norcuron.

Neuromuscular blocker, nondepolarizing.

0.1-0.2 mg/kg IV push. Maintenance dose within 45-60 minutes: 0.8-1.2 mg/kg IV push.

<p>0.1-0.3 mg/kg IV/IO. Maintenance dose within 20-35 minutes: 0.01-0.05 mg/kg IV/IO push.</p> Signup and view all the answers

<p>Neuromuscular agent with intermediate duration of action that competes with acetylcholine for receptors at the motor end plate, resulting in neuromuscular blockade.</p> Signup and view all the answers

<p>Rapid-sequence intubation.</p> Signup and view all the answers

<p>Acute narrow-angle glaucoma, penetrating eye injuries, inability to control airway or support ventilations with oxygen and positive pressure, newborns, myasthenia gravis, hepatic or renal failure.</p> Signup and view all the answers

<p>Weakness, prolonged neuromuscular block, bronchospasm, apnea, dysrhythmias, bradycardia, tachycardia, PVCs, transient hypotension, cardiac arrest, excessive salivation.</p> Signup and view all the answers

<p>Pregnancy safety: Category C. If the patient is conscious, explain the effect of the medication before administration and always sedate the patient before using Vecuronium. Intubation and ventilatory support must be readily available. Monitor the patient carefully. Vecuronium has no effect on consciousness or pain. Will not stop neuronal seizure activity. Pulse rate and cardiac output are increased. Decrease doses for patients with renal disease.</p> Signup and view all the answers